The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis
- PMID: 23406585
- DOI: 10.2500/ajra.2013.27.3829
The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis
Abstract
Background: Most patients with cystic fibrosis (CF) have chronic rhinosinusitis; their sinuses are often colonized with bacteria that can initiate and maintain deleterious pulmonary infections. Theoretically, eradication of the sinus bacteria should reduce the frequency of lung infections and thereby reduce pulmonary morbidity. This article addressed whether bacteria in CF sinuses are eligible for eradication by sinus surgery and postoperative treatment.
Methods: A prospective study including 58 CF patients, who had extensive sinus surgery and growth of Pseudomonas aeruginosa, Achromobacter xylosoxidans, and/or Burkholderia multivorans in their sinuses, was initiated. All patients followed a systematic postoperative treatment program of nasal irrigations with saline and colistimethate sodium and systematic endoscopic cleansing. All patients had follow-up examinations including sinus cultures; each side of the nose was cultured separately.
Results: At the 6-month follow-up visit, 49 patients were cultured; 66 of 98 maxillary-ethmoidal complexes (67%) showed no growth of pathogenic bacteria. Some patients were not free from CF pathogenic bacteria at all cultures; however, 20 (41%) patients had no bilateral regrowth (p < 0.01) and 4 patients had no unilateral regrowth at any time during 6 months of follow-up. The eradication of CF pathogens was accomplished in patients from all three lung infection groups: intermittently colonized, chronically infected, and lung transplanted. The patient with the longest follow-up had no bacterial growth for 3 years.
Conclusion: Extensive sinus surgery combined with intensive follow-up can eradicate pathogenic bacteria from CF sinuses.
Similar articles
-
Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?Rhinology. 2013 Sep;51(3):222-30. doi: 10.4193/Rhino12.207. Rhinology. 2013. PMID: 23943728
-
Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.J Cyst Fibros. 2013 Sep;12 Suppl 2:S1-20. doi: 10.1016/S1569-1993(13)00150-1. J Cyst Fibros. 2013. PMID: 24064077
-
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response.J Cyst Fibros. 2012 Dec;11(6):525-31. doi: 10.1016/j.jcf.2012.04.011. Epub 2012 May 15. J Cyst Fibros. 2012. PMID: 22595452
-
Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses.Dan Med J. 2017 May;64(5):B5361. Dan Med J. 2017. PMID: 28552099 Review.
-
Pathophysiology and management of pulmonary infections in cystic fibrosis.Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. doi: 10.1164/rccm.200304-505SO. Am J Respir Crit Care Med. 2003. PMID: 14555458 Review.
Cited by
-
Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.Case Rep Infect Dis. 2015;2015:438517. doi: 10.1155/2015/438517. Epub 2015 Mar 18. Case Rep Infect Dis. 2015. PMID: 25866686 Free PMC article.
-
Sinus biofilms in patients with cystic fibrosis: is adjusted eradication therapy needed?Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2291-7. doi: 10.1007/s00405-014-3322-x. Epub 2014 Oct 9. Eur Arch Otorhinolaryngol. 2015. PMID: 25297534
-
Surgical Management of Chronic Rhinosinusitis in Cystic Fibrosis.Med Sci (Basel). 2019 Apr 7;7(4):57. doi: 10.3390/medsci7040057. Med Sci (Basel). 2019. PMID: 30959944 Free PMC article. Review.
-
Management of the upper airway in cystic fibrosis.Curr Opin Pulm Med. 2014 Nov;20(6):623-31. doi: 10.1097/MCP.0000000000000107. Curr Opin Pulm Med. 2014. PMID: 25250804 Free PMC article. Review.
-
Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.Eur Respir J. 2021 Apr 8;57(4):2000512. doi: 10.1183/13993003.00512-2020. Print 2021 Apr. Eur Respir J. 2021. PMID: 33093121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical